Newsroom | 21986 results

RALEIGH, N.C.--(BUSINESS WIRE)--Gemelli Biotech's Trio-Smart® 3-Gas Breath Test Featured at DDW 2025....

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced topline results from the Phase 3 portion of the EBO-301 study evaluating epetraborole on top of an optimized background regimen (EBO+OBR) in treatment-refractory MAC lung disease. The truncated Phase 3 portion of the study did not meet its primary endpoint on impr...

GOLDEN, Colo.--(BUSINESS WIRE)--Cuba study shows PharmaJet's Tropis ID needle-free delivery was preferred over needle and syringe by more than 98% of parents and healthcare staff....

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets): Dr. Mark Lewis will be retiring as President of BIOQUAL effective May 31, 2025, and is succeeded by Dr. Hanne Andersen Elyard, BIOQUAL’s Chief Science Officer. Dr. Lewis will remain as Chairman of the Board of Directors. Dr. Lewis joined BIOQUAL as Senior Scientist in August 2003. He became the Executive Vice President in October 2008 and served in that capacity until he became President and CEO in 2010. “The entir...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2025, on May 7, 2025. The Company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET on May 7, 2025. The corporate update and financial results will be provided via a press release shortly after market close and will be accessible on the News page in the Investors section of the Vir Biote...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 12, 2025, at 4:30 p.m. ET to discuss its financial results for the fiscal 2025 second quarter ended March 31, 2025. Webcast and Conference Call and Details Investors may access a live audio webcast on the Events and Presentations page under the Investors section of the Arrowhead website. A replay of the webcast will be available approximately t...

SUNRISE, Fla.--(BUSINESS WIRE)--Interim HealthCare will introduce an extensive care initiative and participate in the 2025 Walk to End Alzheimer’s to raise awareness and funds...

BOSTON--(BUSINESS WIRE)--binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced a new partnership with WellStreet Urgent Care, a leading healthcare provider based in Atlanta, Georgia. WellStreet Urgent Care is taking steps to improve the way patients access sexually transmitted infection (“STI”) treatment and care through advanced Point-of-Care (“POC”) technologies throughout WellStreet Urgent Care locations. The program is pow...

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Citizens Life Sciences Conference on Wednesday, May 7th at 10:30am ET. A webcast of the presentation can be accessed at the following link: https://wsw.com/webcast/jmp65/atxs/1702976. An archived repl...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the 2025 Citizens JMP Life Sciences Conference being held from May 7-8, 2025 in New York. Details of the event is as follows: Citizens JMP Life Sciences Conference Eric...